SCHEMBL5428652

SCHEMBL5428652

O=C(O)CNC(=O)c1c(O)c2c(OCc3ccccc3)cccc2n(Cc2ccccc2)c1=O

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 9/20 0.66
EGLN3 Q9H6Z9 6/20 0.56
EGLN2 Q96KS0 2/20 0.46
HIF1A Q16665 1/20 0.46
KDM4E B2RXH2 1/20 0.46
PLA2G10 O15496 2/20 0.46
PLA2G1B P04054 2/20 0.46
PLA2G2A P14555 2/20 0.46
PLA2G5 P39877 2/20 0.46
PLA2G2E Q9NZK7 2/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PLA2G6 O60733 1/20 0.44
PLA2G2C Q5R387 1/20 0.44
PLA2G12B Q9BX93 1/20 0.44
PLA2G12A Q9BZM1 1/20 0.44
PLA2G2F Q9BZM2 1/20 0.44
PLA2G3 Q9NZ20 1/20 0.44
PLA2G2D Q9UNK4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8238459 0.89 EGLN1 (0.67) EGLN1EGLN3EGLN2HIF1AKDM4E
SCHEMBL8247149 0.85 EGLN1 (0.73) EGLN1EGLN3EGLN2HIF1AKDM4E
SCHEMBL8244112 0.80 EGLN1 (0.57) EGLN1EGLN3EGLN2HIF1AKDM4E
SCHEMBL8244419 0.80 EGLN1 (1.00) EGLN1EGLN3EGLN2HIF1AKDM4E
SCHEMBL5307125 0.79 EGLN1 (0.61) EGLN1EGLN3EGLN2HIF1AKDM4E
SCHEMBL8238447 0.79 EGLN1 (0.70) EGLN1EGLN3EGLN2HIF1AKDM4E
SCHEMBL8247257 0.78 EGLN1 (0.60) EGLN1EGLN3EGLN2HIF1AKDM4E
SCHEMBL8247158 0.78 EGLN1 (0.52) EGLN1EGLN3EGLN2HIF1AMEN1
SCHEMBL2761583 0.77 EDNRA (0.48) EGLN1
SCHEMBL8250095 0.77 EGLN1 (0.70) EGLN1EGLN3EGLN2HIF1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007038571-A2 PROLYL HYDROXYLASE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2007-04-05 WO disclosed